Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?
Authors:
- 29 September 2022
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 187, 107029
Abstract
No abstract availableKeywords
Funding Information
- LEO Pharma
This publication has 25 references indexed in Scilit:
- Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010Seizure: European Journal of Epilepsy, 2014
- Clinical Pharmacology and Pharmacokinetics of LevetiracetamFrontiers in Neurology, 2013
- Host factors affecting antiepileptic drug delivery—Pharmacokinetic variabilityAdvanced Drug Delivery Reviews, 2012
- Age and Comedications Influence Levetiracetam Pharmacokinetics in ChildrenPediatric Neurology, 2010
- Adverse antiepileptic drug effectsNeurology, 2009
- Generic substitution in the treatment of epilepsy: Patient and physician perceptionsEpilepsy & Behavior, 2008
- Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic StrategiesEpilepsia, 2008
- Effect of Age and Comedication on Levetiracetam Pharmacokinetics and TolerabilityEpilepsia, 2007
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000